Unternehmen
Bristol-Myers Squibb Company

Aktueller Kurs
66.54 USD

Symbol
BMY

ISIN
US1101221083

Börse
NYSE

Sektor
Health Care

Marktkapitalisierung
150.364 Mrd. US

Branche
Pharmaceuticals

Dividendenrendite
2.97 %

Ausschüttungsquote
29.68 %

KGV
93.81

KUV (TTM)
3.73

KGVe
8.79

Kursziel
74.76 USD

Unternehmen
Bristol-Myers Squibb Company

Aktueller Kurs
66.54 USD

Symbol
BMY

ISIN
US1101221083

Börse
NYSE

Marktkapitalisierung
150.364 Mrd. USD

Sektor
Health Care

Branche
Pharmaceuticals

Dividendenrendite
2.97 %

Ausschüttungsquote
29.68 %

KGV
93.81

KUV (TTM)
3.73

KGVe
8.79

Kursziel
74.76 USD

Live-Chart (verzögert)

Firmenbeschreibung

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. The company's products include Opdivo for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, it offers Reyataz, a protease inhibitor to treat human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. The company has collaboration agreements with Pfizer, Otsuka, Ono, Nektar, GRYT Health, Ubiquigent Limited, Checkmate Pharmaceuticals, and Sensyne Health plc; clinical collaboration with NeoImmuneTech, Inc.; partnership with Astrazeneca Plc; a discovery collaboration with Insitro, Inc.; and collaboration with Schrödinger, Inc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.

Bristol-Myers Squibb Company Fundamentaldaten

Jahre und Quartale beziehen sich jeweils auf das Geschäftsjahr des Unternehmens. (Das Geschäftsjahr kann ggf. vom Kalenderjahr abweichen.)

Das Geschäftsjahr von Bristol-Myers Squibb Company endet im Dezember.

Gewinn pro Jahr & Quartal (Net Income) in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 -0.775 -0.085 1.872 0.000 1.012
2019 1.710 1.432 1.353 -1.056 3.439
2018 1.486 0.373 1.901 1.160 4.920
2017 1.574 0.916 0.845 -2.328 1.007
2016 1.195 1.166 1.202 0.894 4.457
2015 1.186 -0.130 0.706 -0.197 1.565
2014 0.937 0.333 0.721 0.013 2.004
2013 0.609 0.536 0.692 0.726 2.563
2012 1.101 0.645 -0.711 0.925 1.960
2011 0.986 0.902 0.969 0.852 3.709
2010 0.743 0.927 0.949 0.483 3.102

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 1.72 1.63 1.63 0 4.98
2019 1.1 1.18 1.17 1.22 4.67
2018 0.94 1.01 1.09 0.94 3.98
2017 0.84 0.74 0.75 0.68 3.01
2016 0.74 0.69 0.77 0.63 2.83
2015 0.71 0.53 0.39 0.38 2.01
2014 0.46 0.48 0.45 0.46 1.85
2013 0.41 0.44 0.46 0.51 1.82
2012 0.64 0.48 0.41 0.47 2
2011 0.58 0.56 0.61 0.53 2.28
2010 0.56 0.54 0.59 0.47 2.16

Umsatz pro Jahr & Quartal in Mrd. USD

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 10.781 10.129 10.54 0 31.45
2019 5.92 6.273 6.007 7.945 26.145
2018 5.193 5.704 5.691 5.973 22.561
2017 4.929 5.144 5.254 5.449 20.776
2016 4.391 4.871 4.922 5.243 19.427
2015 4.041 4.163 4.069 4.287 16.56
2014 3.811 3.889 3.921 4.258 15.879
2013 3.831 4.048 4.065 4.441 16.385
2012 5.251 4.443 3.736 4.191 17.621
2011 5.011 5.434 5.345 5.454 21.244
2010 4.807 4.768 4.798 5.111 19.484

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 4.77 4.48 4.60 0.00 268.80
2019 3.62 3.83 3.68 4.64 15.27
2018 3.17 3.49 3.48 3.65 13.78
2017 2.95 3.12 3.19 3.30 12.58
2016 2.61 2.90 2.93 3.12 11.56
2015 2.41 2.50 2.42 2.55 9.86
2014 2.29 2.33 2.35 2.55 9.51
2013 2.31 2.44 2.45 2.67 9.86
2012 3.08 2.61 2.24 2.48 10.44
2011 2.92 3.16 3.12 3.18 12.37
2010 2.79 2.76 2.78 2.96 11.28

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 0.00 0.00 0.00 -100.00 -70.57
2019 47.41 -16.26 -5.52 -178.05 -30.10
2018 0.00 -74.90 409.65 -38.98 388.58
2017 76.06 -41.80 -7.75 -375.50 -77.41
2016 0.00 -2.43 3.09 -25.62 184.79
2015 9023.08 -110.96 0.00 -127.90 -21.91
2014 29.06 -64.46 116.52 -98.20 -21.81
2013 -34.16 -11.99 29.10 4.91 30.77
2012 29.23 -41.42 -210.23 0.00 -47.16
2011 104.14 -8.52 7.43 -12.07 19.57
2010 -90.69 24.76 2.37 -49.10 -70.65

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 35.70 -6.05 4.06 0.00 0.00
2019 -0.89 5.96 -4.24 32.26 15.89
2018 -4.70 9.84 -0.23 4.96 8.59
2017 -5.99 4.36 2.14 3.71 6.94
2016 2.43 10.93 1.05 6.52 17.31
2015 -5.10 3.02 -2.26 5.36 4.29
2014 -14.19 2.05 0.82 8.59 -3.09
2013 -8.59 5.66 0.42 9.25 -7.01
2012 -3.72 -15.39 -15.91 12.18 -17.05
2011 -1.96 8.44 -1.64 2.04 9.03
2010 -4.49 -0.81 0.63 6.52 -3.67

Bristol-Myers Squibb Company Fundamentaldaten

Gewinn pro Jahr & Quartal (Net Income)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.000 0.000 0.000 0.000 0.000
2020 -0.775 -0.085 1.872 0.000 1.012
2019 1.710 1.432 1.353 -1.056 3.439
2018 1.486 0.373 1.901 1.160 4.920
2017 1.574 0.916 0.845 -2.328 1.007
2016 1.195 1.166 1.202 0.894 4.457
2015 1.186 -0.130 0.706 -0.197 1.565
2014 0.937 0.333 0.721 0.013 2.004
2013 0.609 0.536 0.692 0.726 2.563
2012 1.101 0.645 -0.711 0.925 1.960
2011 0.986 0.902 0.969 0.852 3.709
2010 0.743 0.927 0.949 0.483 3.102

Gewinn je Aktie (EPS) pro Jahr & Quartal (non-GAAP)

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 1.72 1.63 1.63 0 4.98
2019 1.1 1.18 1.17 1.22 4.67
2018 0.94 1.01 1.09 0.94 3.98
2017 0.84 0.74 0.75 0.68 3.01
2016 0.74 0.69 0.77 0.63 2.83
2015 0.71 0.53 0.39 0.38 2.01
2014 0.46 0.48 0.45 0.46 1.85
2013 0.41 0.44 0.46 0.51 1.82
2012 0.64 0.48 0.41 0.47 2
2011 0.58 0.56 0.61 0.53 2.28
2010 0.56 0.54 0.59 0.47 2.16

Umsatz pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0 0 0 0 0
2020 10.781 10.129 10.54 0 31.45
2019 5.92 6.273 6.007 7.945 26.145
2018 5.193 5.704 5.691 5.973 22.561
2017 4.929 5.144 5.254 5.449 20.776
2016 4.391 4.871 4.922 5.243 19.427
2015 4.041 4.163 4.069 4.287 16.56
2014 3.811 3.889 3.921 4.258 15.879
2013 3.831 4.048 4.065 4.441 16.385
2012 5.251 4.443 3.736 4.191 17.621
2011 5.011 5.434 5.345 5.454 21.244
2010 4.807 4.768 4.798 5.111 19.484

Umsatz je Aktie pro Jahr & Quartal

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 4.77 4.48 4.60 0.00 268.80
2019 3.62 3.83 3.68 4.64 15.27
2018 3.17 3.49 3.48 3.65 13.78
2017 2.95 3.12 3.19 3.30 12.58
2016 2.61 2.90 2.93 3.12 11.56
2015 2.41 2.50 2.42 2.55 9.86
2014 2.29 2.33 2.35 2.55 9.51
2013 2.31 2.44 2.45 2.67 9.86
2012 3.08 2.61 2.24 2.48 10.44
2011 2.92 3.16 3.12 3.18 12.37
2010 2.79 2.76 2.78 2.96 11.28

Gewinn-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 -100.00
2020 0.00 0.00 0.00 -100.00 -70.57
2019 47.41 -16.26 -5.52 -178.05 -30.10
2018 0.00 -74.90 409.65 -38.98 388.58
2017 76.06 -41.80 -7.75 -375.50 -77.41
2016 0.00 -2.43 3.09 -25.62 184.79
2015 9023.08 -110.96 0.00 -127.90 -21.91
2014 29.06 -64.46 116.52 -98.20 -21.81
2013 -34.16 -11.99 29.10 4.91 30.77
2012 29.23 -41.42 -210.23 0.00 -47.16
2011 104.14 -8.52 7.43 -12.07 19.57
2010 -90.69 24.76 2.37 -49.10 -70.65

Umsatz-Wachstum in Prozent

Q1
Jan-Mrz
Q2
Apr-Jun
Q3
Jul-Sep
Q4
Okt-Dez
Jahr
Jan-Dez
2021 0.00 0.00 0.00 0.00 0.00
2020 35.70 -6.05 4.06 0.00 0.00
2019 -0.89 5.96 -4.24 32.26 15.89
2018 -4.70 9.84 -0.23 4.96 8.59
2017 -5.99 4.36 2.14 3.71 6.94
2016 2.43 10.93 1.05 6.52 17.31
2015 -5.10 3.02 -2.26 5.36 4.29
2014 -14.19 2.05 0.82 8.59 -3.09
2013 -8.59 5.66 0.42 9.25 -7.01
2012 -3.72 -15.39 -15.91 12.18 -17.05
2011 -1.96 8.44 -1.64 2.04 9.03
2010 -4.49 -0.81 0.63 6.52 -3.67

Bristol-Myers Squibb Company Dividenden-Entwicklung

Ex-Tag Record Date Zahltag Dividende
2020-12-31 2021-01-04 2021-02-01 0.49
2020-10-01 2020-10-02 2020-11-02 0.45
2020-07-02 2020-07-06 2020-08-03 0.45
2020-04-02 2020-04-03 2020-05-01 0.45
2020-01-02 2020-01-03 2020-02-03 0.45
2019-10-03 2019-10-04 2019-11-01 0.41
2019-07-03 2019-07-05 2019-08-01 0.41
2019-04-04 2019-04-05 2019-05-01 0.41
2019-01-03 2019-01-04 2019-02-01 0.41
2018-10-04 2018-10-05 2018-11-01 0.4
2018-07-05 2018-07-06 2018-08-01 0.4
2018-04-05 2018-04-06 2018-05-01 0.4
2018-01-04 2018-01-05 2018-02-01 0.4
2017-10-05 2017-10-06 2017-11-01 0.39
2017-07-05 2017-07-07 2017-08-01 0.39
2017-04-05 2017-04-07 2017-05-01 0.39
2017-01-04 2017-01-06 2017-02-01 0.39
2016-10-05 2016-10-07 2016-11-01 0.38
2016-06-29 2016-07-01 2016-08-01 0.38
2016-03-30 2016-04-01 2016-05-02 0.38